Healthcare Marketing Blogs
08|04|25
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology
CHICAGO – August 4, 2025 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built on Google Cloud technology. The AI Agency, actively deployed and validated for multiple pharmaceutical brands, is 80% AI-powered and automated, reducing marketing costs and […]
07|10|25
Cannes 2025: How CMOs Define The Future of Work and What’s to Come
Each year, the Cannes Lions International Festival of Creativity brings together the world’s most visionary marketers—and 2025 was no exception. Among the attendees was Angela Tenuta, Global Group President at EVERSANA INTOUCH, who shared her reflections in a recent PharmaLive article after joining peers from around the world to explore the evolving role of marketing leadership.
07|01|25
Cannes 2025: Lessons in Branding, AI and the Rise of Creator Content
In his PharmaLive article, John Kenny explores how brands have shifted from speculating about AI to integrating it into creative workflows. From collapsing production timelines to evolving influencer content, discover how AI is reshaping pharma marketing.
06|24|25
Cannes 2025: Pharma’s Creative Inflection Point
In her latest PharmaLive article, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, reflects on three key themes from this year’s Cannes Lions Festival of Creativity—each signaling a new era for pharmaceutical marketing.
06|16|25
MM+M Top 100 2025: Evolved for Where Pharma’s Going
Discover how EVERSANA INTOUCH secured a top 10 spot in the MM+M Agency 100 list and learn how we've evolved for where pharma's going with a unique approach to pharma marketing.
06|13|25
AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era
At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]
06|10|25
AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025
At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care.
05|21|25
Big Moves for Bigger Impact: Elevating Agency Leadership to Enhance Client Success
EVERSANA INTOUCH announced new leadership appointments in a recent press release. Read the blog for details about the leadership changes and how they will enhance client success.
05|21|25
EVERSANA Elevates Agency Leadership Team with Key Talent to Drive Innovation and Maximize Impact for Pharma Brands
CHICAGO– May 21, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced new appointments to the company’s global agency network, EVERSANA INTOUCH, to meet growing client needs.
04|07|25
The Foundations of AI Success: A Conversation from Adobe Summit
Download the POV to hear from EVERSANA INTOUCH experts who were on the ground at the 2025 Adobe Summit. Learn about the necessary work needed to unlock the potential AI for your brand.